88 results
Page 3 of 5
8-K
EX-99.1
sf61utn
6 Jul 22
Other Events
5:15pm
8-K
EX-99.1
85978 1a5hskt
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am
8-K
EX-99.2
yug7 mdu4m1b
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am
8-K
EX-99.1
po83 zo2d5
19 May 22
Other Events
4:05pm
8-K
EX-99.1
qxejetch
12 May 22
Immunome Reports First Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
g8zgmgx6oex
28 Mar 22
Immunome Reports Fourth Quarter and Full Year 2021 Financial Results
8:14am
8-K
EX-99.1
3piju
11 Mar 22
FDA Lifts Clinical Hold on Immunome’s IMM-BCP-01 IND Application for the Treatment of COVID-19
2:33pm
8-K
EX-99.1
t5h 38wrcrat
8 Feb 22
Other Events
8:27am
8-K
EX-99.1
nm244uwp5
10 Jan 22
Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19
4:52pm
8-K
EX-99.1
0uoze10halzmn
29 Nov 21
Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
7:14am
8-K
a6h2vj
18 Oct 21
Regulation FD Disclosure
4:27pm
8-K
EX-99.1
34og0jgjv
18 Oct 21
Regulation FD Disclosure
4:27pm
8-K
tlxeupwtsy qbu85pgu2
21 Sep 21
Regulation FD Disclosure
7:40am
8-K
EX-99.1
33eoez6yv0 rzsfe
21 Sep 21
Regulation FD Disclosure
7:40am
8-K
flme20q6
8 Sep 21
Other Events
4:55pm
8-K
EX-99.1
8kyt2viadb13 27e0
8 Sep 21
Other Events
4:55pm